{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:28:27Z","timestamp":1762522107354,"version":"3.37.3"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III integrated in the Plan Nacional de I+D+I and cofunded by the ISCIII-Subdirecci\u00f3n General de Evaluaci\u00f3n and the Fondo Europeo de Desarrollo Regional (FEDER)","award":["(PI 13\/01546 and PI16\/01912),"],"award-info":[{"award-number":["(PI 13\/01546 and PI16\/01912),"]}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Societat Catalana de Reumatologia (SCR)"},{"name":"CERCA Programme\/Generalitat de Catalunya"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189202","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T13:34:23Z","timestamp":1512653663000},"page":"e0189202","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immune-mediated inflammatory diseases differently affect IGRAs\u2019 accuracy for latent tuberculosis infection diagnosis in clinical practice"],"prefix":"10.1371","volume":"12","author":[{"given":"Irene","family":"Latorre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Manuel","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Naves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Villar-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeni","family":"Dom\u00e8nech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ferr\u00e1ndiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-0309","authenticated-orcid":true,"given":"Jose","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"L Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3899\/jrheum.140102","article-title":"Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance","volume":"91","author":"F Cantini","year":"2014","journal-title":"J Rheumatol Suppl"},{"issue":"9235","key":"ref3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"P Andersen","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent <italic>Mycobacterium tuberculosis<\/italic> infection: a systematic review and meta-analysis","volume":"37","author":"R Diel","year":"2011","journal-title":"Eur Respir J"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/CVI.00364-07","article-title":"Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis","volume":"15","author":"J Dominguez","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"9519","key":"ref6","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with <italic>Mycobacterium tuberculosis<\/italic>: a prospective study","volume":"367","author":"G Ferrara","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.crohns.2008.05.007","article-title":"Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents","volume":"2","author":"J Dominguez","year":"2008","journal-title":"J Crohns Colitis"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","article-title":"IFN-gamma release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults","volume":"188","author":"G Redelman-Sidi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study","volume":"190","author":"M Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13126836","article-title":"Diagnosis and treatment of tuberculosis","volume":"44","author":"J Ruiz-Manzano","year":"2008","journal-title":"Arch Bronconeumol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review","volume":"4","author":"RN van Zyl-Smit","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10067-012-1938-z","article-title":"Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment","volume":"31","author":"S Minguez","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jinf.2014.07.026","article-title":"Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis","volume":"69","author":"I Latorre","year":"2014","journal-title":"J Infect"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-012-0192-7","article-title":"Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases","volume":"13","author":"JM Ramos","year":"2013","journal-title":"Clin Exp Med"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1097\/MIB.0000000000000147","article-title":"Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients","volume":"20","author":"SH Wong","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"E Belard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/acr.22454","article-title":"Evaluating indeterminate interferon-gamma-release assay results in patients with chronic inflammatory diseases receiving immunosuppressive therapy","volume":"67","author":"C Calabrese","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.crohns.2011.09.011","article-title":"Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients","volume":"6","author":"U Helwig","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"e0103763","DOI":"10.1371\/journal.pone.0103763","article-title":"Fluctuating Behavior and Influential Factors in the Performance of the QuantiFERON-TB Gold In-Tube Assay in the Diagnosis of Tuberculosis","volume":"10","author":"L Bao","year":"2015","journal-title":"PloS one"},{"key":"ref20","article-title":"Corticosteroids and infliximab impair the performance of interferon-gamma release assays used for diagnosis of latent tuberculosis","author":"A Edwards","year":"2017","journal-title":"Thorax"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CVI.00132-07","article-title":"Discrepancy between <italic>Mycobacterium tuberculosis<\/italic>-specific gamma interferon release assays using short and prolonged in vitro incubation","volume":"14","author":"EM Leyten","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-9-182","article-title":"New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response","volume":"9","author":"O Butera","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"e6686","DOI":"10.1371\/journal.pone.0006686","article-title":"Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers","volume":"4","author":"I Casas","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/00365548.2014.938691","article-title":"Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay","volume":"46","author":"HC Kim","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eimc.2015.11.021","article-title":"Executive summary of the guidelines for the use of interferon-gamma release assays in the diagnosis of tuberculosis infection","volume":"34","author":"M Santin","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2340\/00015555-1106","article-title":"Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease","volume":"91","author":"ID Bassukas","year":"2011","journal-title":"Acta dermato-venereologica"},{"key":"ref27","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","author":"L Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB Gold Plus for detection of <italic>Mycobacterium tuberculosis<\/italic> infection in Japan","volume":"6","author":"L Yi","year":"2016","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.05.006","article-title":"Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT","author":"H Hoffmann","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus","volume":"73","author":"E Petruccioli","year":"2016","journal-title":"J Infect"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jinf.2014.06.013","article-title":"IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children","volume":"69","author":"I Latorre","year":"2014","journal-title":"J Infect"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with <italic>Mycobacterium tuberculosis<\/italic>","volume":"43","author":"NN Chegou","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"ref33","first-page":"93","article-title":"Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis","volume":"7","author":"SJ Guo","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jinf.2017.07.004","article-title":"Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases","volume":"75","author":"R Villar-Hernandez","year":"2017","journal-title":"J Infect"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:37:44Z","timestamp":1540269464000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189202"}},"subtitle":[],"editor":[{"given":"Thomas J","family":"Scriba","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189202","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}